Castleark Management LLC Nevro Corp Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $7.38 Million - $10.1 Million	-55,555 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$138.17 - $184.34 $3.15 Million - $4.21 Million	-22,825 Reduced 29.12%	55,555 $9.62 Million
Q3 2020 Nov 16, 2020	BUY	$114.09 - $145.51 $1.36 Million - $1.74 Million	11,947 Added 17.98%	78,380 $10.9 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $1.4 Million - $2.03 Million	-15,645 Reduced 19.06%	66,433 $7.94 Million
Q1 2020 May 13, 2020	BUY	$70.23 - $144.31 $5.76 Million - $11.8 Million	82,078 New	82,078 $8.21 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.